This is a prospective study to compare the safety and efficacy of treating small aneurysms.
We participated in a post-market safety study to evaluate the new Apollo Onyx micro catheter. The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Micro Catheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.
If you would like to explore more clinical information about this trial, please see the trial page on ClinicalTrials.gov
You Might Also Enjoy...
This is a prospective study to compare the safety and efficacy of treating small aneurysms.
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.